For patients planning to discontinue, the protocol accelerates recovery and prevents permanent accumulated damage during the wind-down period
Most-engaged members lost 25.2% more weight at week 40 and persisted 2.2x longer on medication program than least-engaged members using the Noom app, demonstrating the benefits of combining GLP-1 medication with Nooms GLP-1 Companion behavior-change program PRINCETON, N.J., February 4, 2026 Noom, the leading behavior change company, today shared new real-world findings from tens of thousands of members, showing a clear relationship: members who engage more with Nooms leading GLP-1 Companion app tend to lose more weight and stay on a medication program longer
GLYNAC is the body's master antioxidant and an anti-ageing powerhouse
Its main role is to stimulate insulin secretion, which improves glucose levels and insulin tolerance, and as a result reduces hyperglycemia (high blood sugar)
Current data remains too limited to definitively confirm or rule out fetal risks, so discontinuation is the safest first step